These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 13918641)

  • 21. An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study.
    Allman S; Norris RJ
    J Int Med Res; 1990; 18 Suppl 2():17B-23B. PubMed ID: 2193840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guanethidine and cyclopenthiazide in the treatment of hypertension.
    FOX CA
    Practitioner; 1962 Jul; 189():79-82. PubMed ID: 13894364
    [No Abstract]   [Full Text] [Related]  

  • 23. A study comparing indapamide with cyclopenthiazide in geriatric patients.
    Khan AU
    Postgrad Med J; 1981; 57 Suppl 2():42-3. PubMed ID: 7033945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxprenolol plus cyclopenthiazide-KCl versus methyldopa in the treatment of hypertension.
    Seedat YK
    S Afr Med J; 1979 Jan; 55(4):114. PubMed ID: 424946
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1978 Nov; 32(11):326-32. PubMed ID: 737111
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I; Brym E
    Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
    [No Abstract]   [Full Text] [Related]  

  • 27. The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
    Forrest WA
    Practitioner; 1982 Apr; 226(1366):777-8. PubMed ID: 7045851
    [No Abstract]   [Full Text] [Related]  

  • 28. [Stability of hydrochlorothiazide and cyclopenthiazide in various drug forms. 1. Stability of hydrochlorothiazide and cyclopenthiazide].
    Hennig B; Scholz F
    Pharmazie; 1984 Nov; 39(11):779-80. PubMed ID: 6531386
    [No Abstract]   [Full Text] [Related]  

  • 29. Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
    Levenstein JH
    S Afr Med J; 1978 Nov; 54(21):860-4. PubMed ID: 371021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CLINICAL FINDINGS WITH CYCLOPENTHIAZIDE.
    ALI A; COUTINHO AA; HUSAIN M
    J Indian Med Assoc; 1964 Feb; 42():155-63. PubMed ID: 14115856
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of a new saluretic in the treatment of obesity:cyclopenthiazide].
    DE VITA JA
    Dia Med; 1961 Dec; 33():2904-8. PubMed ID: 13884589
    [No Abstract]   [Full Text] [Related]  

  • 32. Prazosin alone and combined with a thiazide diuretic in the treatment of hypertension.
    Seedat YK; Seedat MA; Bhoola R
    S Afr Med J; 1977 Apr; 51(14):461-3. PubMed ID: 860171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.
    Elsdon-Dew RW; Holden E
    J Int Med Res; 1981; 9(5):315-8. PubMed ID: 7028531
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical tests of the hypotensive, sedative, diuretic, hypoazotemic and pulse-rate-modifying effects of extracts of Cartaegus oxycantha-hypericum and Orthosiphon stamineus contained in the Schoum hypotensive drug].
    BELTRAMETTI L; ZAMPORI O
    Gazz Med Ital; 1954 Sep; 113(9):281-5. PubMed ID: 13232217
    [No Abstract]   [Full Text] [Related]  

  • 35. [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
    Gyntelberg F; Jacobsen K; Martlev A; Backer P
    Ugeskr Laeger; 1977 Mar; 139(11):641-6. PubMed ID: 320734
    [No Abstract]   [Full Text] [Related]  

  • 36. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
    Forrest WA; Bridgman KM; Ebbutt AF
    Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
    [No Abstract]   [Full Text] [Related]  

  • 37. An open comparison between free and a fixed combination of diuretic and beta-blocker in the management of essential hypertension.
    Forrest WA
    J Int Med Res; 1980; 8(2):127-31. PubMed ID: 6102939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study of the 3,4,5-trimethoxycinnamate of reserpyl, (T.C.R.) new hypotensive alkaloid of Rauwolfia serpentina].
    BERNARD JG; MONCEAUX JP
    Vie Med; 1959 Sep; 40():807-22. PubMed ID: 13799660
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical experience with a new oral diuretic--cyclopenthiazide. A comparative study with mercurial and other nonmercurial diuretics.
    DAS PK; DAS P; CHATTERJEE SC
    J Indian Med Assoc; 1963 Apr; 40():368-72. PubMed ID: 14025181
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical observations on the diuretic, saluretic and hypotensive effect of a sulfonamide derivative of benzophenone].
    BERETERVIDE JJ; RODRIGUEZ CASTELO JL
    Prensa Med Argent; 1961 Apr; 48():1215-20. PubMed ID: 13867527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.